Spinal Stargazin-Mediated Cross-Talk of AMPA/NMDA Receptors in Chronic Pain

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4172/2324-903X.1000101
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Stargazin and AMPA receptor membrane expression is increased in the somatosensory cortex of Genetic Absence Epilepsy Rats from Strasbourg.

  2011cited by this paper
• Stargazin (TARP γ-2) Is Required for Compartment-Specific AMPA Receptor Trafficking and Synaptic Plasticity in Cerebellar Stellate Cells

  2011cited by this paper
• Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2.

  2010cited by this paper
• Cell-permeable peptide Tat-PSD-95 PDZ2 inhibits chronic inflammatory pain behaviors in mice.

  2008cited by this paper
• Efficacy of mu‐opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials

  2006cited by this paper
• New role for spinal Stargazin in α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor‐mediated pain sensitization after inflammation

  2006cited by this paper
• Stargazin Reduces Desensitization and Slows Deactivation of the AMPA-Type Glutamate Receptors

  2005cited by this paper
• Stargazin is an AMPA receptor auxiliary subunit.

  2005cited by this paper
• Stargazin modulates AMPA receptor gating and trafficking by distinct domains

  2005cited by this paper
• Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.

  2005cited by this paper
• Bidirectional synaptic plasticity regulated by phosphorylation of stargazin-like TARPs.

  2005cited by this paper
• Stargazin Modulates Native AMPA Receptor Functional Properties by Two Distinct Mechanisms

  2005cited by this paper
• Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies

  2005cited by this paper
• Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.

  2004cited by this paper
• AMPA receptor-dependent clustering of synaptic NMDA receptors is mediated by Stargazin and NR2A/B in spinal neurons and hippocampal interneurons.

  2004influential reference
• Dynamic Interaction of Stargazin-like TARPs with Cycling AMPA Receptors at Synapses

  2004cited by this paper
• A novel action of stargazin as an enhancer of AMPA receptor activity.

  2004cited by this paper
• Interaction of transmembrane AMPA receptor regulatory proteins with multiple membrane associated guanylate kinases.

  2003cited by this paper
• Antinociceptive Activity of the N-Methyl-d-aspartate Receptor Antagonist N-(2-Indanyl)-glycinamide Hydrochloride (CHF3381) in Experimental Models of Inflammatory and Neuropathic Pain

  2003cited by this paper
• Specific involvement in neuropathic pain of AMPA receptors and adapter proteins for the GluR2 subunit.

  2003cited by this paper
• Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins

  2003cited by this paper
• Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

  2003cited by this paper
• Role of postsynaptic density protein-95 in the maintenance of peripheral nerve injury-induced neuropathic pain in rats.

  2003cited by this paper
• New Indications for Treatment of Chronic Inflammation by TNF-&agr; Blockade

  2003cited by this paper
• Phosphorylation of the Postsynaptic Density-95 (PSD-95)/Discs Large/Zona Occludens-1 Binding Site of Stargazin Regulates Binding to PSD-95 and Synaptic Targeting of AMPA Receptors

  2002influential reference
• Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.

  2002cited by this paper
• Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number

  2002influential reference
• Development of anti-TNF therapy for rheumatoid arthritis

  2002cited by this paper
• Phosphorylation of Stargazin by Protein Kinase A Regulates Its Interaction with PSD-95*

  2002cited by this paper
• Selective upregulation of the flip-flop splice variants of AMPA receptor subunits in the rat spinal cord after hindpaw inflammation.

  2001cited by this paper
• Biochemical and anatomical evidence for specialized voltage-dependent calcium channel gamma isoform expression in the epileptic and ataxic mouse, stargazer.

  2001cited by this paper
• Knockdown of PSD-95/SAP90 delays the development of neuropathic pain in rats

  2001cited by this paper
• Characterization of the glutamatergic system for induction and maintenance of allodynia.

  2001cited by this paper
• Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization.

  2000cited by this paper
• A Stargazer Foretells the Way to the Synapse

  2000cited by this paper
• Synaptic plasticity and dynamic modulation of the postsynaptic membrane

  2000cited by this paper
• Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting.

  2000cited by this paper
• LTP mechanisms: from silence to four-lane traffic.

  2000cited by this paper
• Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.

  2000cited by this paper
• Synaptic activity at calcium-permeable AMPA receptors induces a switch in receptor subtype

  2000cited by this paper
• Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms

  2000influential reference
• Hippocampal LTD expression involves a pool of AMPARs regulated by the NSF-GluR2 interaction.

  1999cited by this paper
• The role of non-N-methyl-D-aspartate ionotropic glutamate receptors in the spinal transmission of nociception in normal animals and animals with carrageenan inflammation.

  1999cited by this paper
• Impaired cerebellar synapse maturation in waggler, a mutant mouse with a disrupted neuronal calcium channel gamma subunit.

  1999cited by this paper
• AMPA receptor–PDZ interactions in facilitation of spinal sensory synapses

  1999cited by this paper
• Impairment of AMPA Receptor Function in Cerebellar Granule Cells of Ataxic Mutant Mouse Stargazer

  1999cited by this paper
• PSD-95 Assembles a Ternary Complex with theN-Methyl-d-aspartic Acid Receptor and a Bivalent Neuronal NO Synthase PDZ Domain*

  1999cited by this paper
• Interaction of the N-ethylmaleimide-sensitive factor with AMPA receptors.

  1998cited by this paper
• NSF binding to GluR2 regulates synaptic transmission.

  1998cited by this paper
• Morphine, the NMDA receptor antagonist MK801 and the tachykinin NK1 receptor antagonist RP67580 attenuate the development of inflammation‐induced progressive tactile hypersensitivity

  1998cited by this paper
• Neuropharmacology of AMPA and kainate receptors.

  1998cited by this paper
• Pre-emptive intrathecal Mk-801, a non-competitive N-methyl-D-aspartate receptor antagonist, inhibits the up-regulation of spinal dynorphin mRNA and hyperalgesia in a rat model of chronic inflammation.

  1998cited by this paper
• The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit.

  1998cited by this paper
• Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: Central and peripheral components

  1997cited by this paper
• Apparent antinociceptive and anti-inflammatory effects of GYKI 52466.

  1997cited by this paper
• Upregulation of spinal glutamate receptors in chronic pain.

  1996cited by this paper
• NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride

  1996cited by this paper
• Treatment of a chronic allodynia‐like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists

  1996cited by this paper
• Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice

  1995cited by this paper
• Evidence for silent synapses: implications for the expression of LTP.

  1995cited by this paper
• Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95.

  1995cited by this paper
• Requirement of Metabotropic Glutamate Receptors for the Generation of Inflammation‐evoked Hyperexcitability in Rat Spinal Cord Neurons

  1994cited by this paper
• Differential effects of N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists on the responses of rat spinal neurons with joint input.

  1993cited by this paper
• The effects of a non‐competitive NMDA receptor antagonist, MK‐801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation

  1992cited by this paper
• Excitatory amino acids and synaptic transmission: the evidence for a physiological function.

  1990cited by this paper

• A Review on Liver Exploring upon Toxic Substances like Alcohol Poisoning

  2016cites this paper
• Serine Racemase Regulated by Binding to Stargazin and PSD-95

  2014cites this paper